» Articles » PMID: 34013801

Lipid Profiles in Users of Combustible and Electronic Cigarettes

Abstract

Electronic cigarette use has especially risen among adolescents and young adults. The aim of this study was to investigate fasting blood glucose and lipid profiles in chronic combustible cigarette and electronic cigarette users. We evaluated participants aged 21 to 45 ( = 525, mean age 31 ± 7 years, 45% women) without established cardiovascular disease or risk factors who were combustible cigarette users ( = 290), electronic cigarette users ( = 131; 65 sole users and 66 dual users), or never users ( = 104). In the first wave of enrollment (2014-2017), electronic cigarette users reported their products as first, second and third generation devices (e-cig users) and were all largely current (i.e., dual) or former (sole) combustible cigarette users, whereas in the second wave of enrollment (2019-2020), electronic cigarette users all reported pod-based device use (pod users) and included more sole users who were never smokers. In multivariable-adjusted analyses comparing to never users, both sole e-cig users and combustible cigarette users had higher glucose and triglycerides and lower high-density lipoprotein (HDL) cholesterol levels. Dual e-cig users showed higher triglycerides and very-low-density lipoprotein cholesterol, and lower HDL cholesterol compared to never users. In contrast, pod users (both sole and dual) had lipid profiles and glucose levels similar to never users. Overall, users of early generation electronic cigarettes display adverse metabolic profiles. In contrast, pod-based electronic cigarette users have similar lipid profiles to never users. Future studies are needed to understand the cumulative effects of electronic cigarette use on cardiometabolic health.

Citing Articles

E-cigarettes and arterial health: A review of the link between vaping and atherosclerosis progression.

Hassan M, Vinagolu-Baur J, Li V, Frasier K, Herrick G, Scotto T World J Cardiol. 2024; 16(12):707-719.

PMID: 39734821 PMC: 11669975. DOI: 10.4330/wjc.v16.i12.707.


Differences in health care provider screening for tobacco use among youth in the United States: The National Youth Tobacco Survey, 2021.

Agbonlahor O, Mattingly D, Rai J, Hart J, McLeish A, Walker K Prev Med. 2023; 175:107718.

PMID: 37793477 PMC: 10681140. DOI: 10.1016/j.ypmed.2023.107718.


Electronic Nicotine Delivery Systems and Cardiovascular/Cardiometabolic Health.

Mears M, Hookfin H, Bandaru P, Vidal P, Stanford K, Wold L Circ Res. 2023; 132(9):1168-1180.

PMID: 37104558 PMC: 10154046. DOI: 10.1161/CIRCRESAHA.123.321565.


The Relationship of Cholesterol Responses to Mitochondrial Dysfunction and Lung Inflammation in Chronic Obstructive Pulmonary Disease.

Jundi B, Ahmed H, Reece J, Geraghty P Medicina (Kaunas). 2023; 59(2).

PMID: 36837454 PMC: 9958740. DOI: 10.3390/medicina59020253.


The Effect of Hyperlipidemia on the Course of Diabetic Retinopathy-Literature Review.

Bryl A, Mrugacz M, Falkowski M, Zorena K J Clin Med. 2022; 11(10).

PMID: 35628887 PMC: 9146710. DOI: 10.3390/jcm11102761.


References
1.
Benowitz N, Burbank A . Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends Cardiovasc Med. 2016; 26(6):515-23. PMC: 4958544. DOI: 10.1016/j.tcm.2016.03.001. View

2.
Craig W, Palomaki G, Haddow J . Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 1989; 298(6676):784-8. PMC: 1836079. DOI: 10.1136/bmj.298.6676.784. View

3.
Kim T, Choi H, Kang J, Kim J . Association between electronic cigarette use and metabolic syndrome in the Korean general population: A nationwide population-based study. PLoS One. 2020; 15(8):e0237983. PMC: 7442237. DOI: 10.1371/journal.pone.0237983. View

4.
Tan X, Jiao G, Ren Y, Gao X, Ding Y, Wang X . Relationship between smoking and dyslipidemia in western Chinese elderly males. J Clin Lab Anal. 2008; 22(3):159-63. PMC: 6649235. DOI: 10.1002/jcla.20235. View

5.
MacDonald A, Middlekauff H . Electronic cigarettes and cardiovascular health: what do we know so far?. Vasc Health Risk Manag. 2019; 15:159-174. PMC: 6592370. DOI: 10.2147/VHRM.S175970. View